{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "P",
  "name": "Everpure, Inc.",
  "url": "https://frontierpicks.com/dossiers/P/",
  "json_url": "https://frontierpicks.com/dossiers/P.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a2",
    "n": 2
  },
  "current_thesis": "Everpure’s hyperscaler expansion supports a recovery thesis that needs quantified fiscal-2028 revenue at the September 23, 2026 analyst meeting and a weekly close above $110. A weekly close below $92 invalidates the case.",
  "invalidation_trigger": "A weekly close below $92 invalidates the hyperscaler-led recovery thesis; this retains the research boundary published on 2026-09-05.",
  "catalyst_date": "2026-09-21",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "ai-datacenter-infrastructure"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Fiscal calendar is offset: Q2 FY2027 covers the quarter ended 2026-08-02, so \"fiscal 2028\" revenue begins roughly February 2027.",
    "Guidance ranges are non-GAAP operating income; GAAP results are reported alongside them (Q2 FY2027 GAAP EPS $0.21 vs non-GAAP $0.70).",
    "Hyperscaler master supply agreements are disclosed without committed volumes or contract value; any sizing comes from management commentary, not the filed document.",
    "Results are released after the US close on report day, with the conference call at 2:00 p.m. PT the same afternoon.",
    "Third-party quote and market-cap figures for this name have been inconsistent across vendors; the adjusted daily close series is the reference used here.",
    "Quarterly institutional-holdings disclosures are lagged quarter-end snapshots, so a newly reported stake is not evidence of a current position."
  ],
  "body_markdown": "## Current Thesis\n\nEverpure’s hyperscaler expansion supports a recovery thesis that needs a quantified fiscal-2028 revenue framework at the September 23 analyst meeting and a weekly close above $110; a weekly close below $92 invalidates it. The fundamental support remains the August 26, 2026 earnings release: fiscal-2027 revenue guidance of $5.03 billion–$5.07 billion and second-quarter revenue of $1.19 billion. The next test is whether management connects that reported growth to the second hyperscaler agreement announced on August 10, 2026.\n\nThe measured change since the September 5 note is improved price momentum. The supplied adjusted series records a September 18, 2026 close of $104.14 and a 14-day relative strength index (RSI) of 64.4, versus $99.51 and 32.6 on September 4. The latest close remains below the August 21 close of $108.55 and the previously identified $110 recovery threshold; the inference is partial repair rather than a completed recovery.\n\nThe narrative is saturated — twelve analyst actions on August 27–28 established broad coverage, while the September 18 close remained 11.9% below the supplied 52-week high. That is an interpretation of attention and price response, not a measurement of investor holdings. A quantified hyperscale framework on September 23 followed by a weekly close above $110 would overturn the view that familiar headlines are failing to extend the repricing.\n\n## Bull Case\n\n- **Reported growth supports the expansion:** The August 26, 2026 results reported second-quarter revenue of $1.19 billion, up 38% year over year, against guidance of $1.095 billion–$1.105 billion. Non-GAAP operating income was $230 million against guidance of $195 million–$205 million, according to the supplied earnings-release record.\n- **Recurring revenue provides separate support:** The August 26, 2026 release reported subscription annual recurring revenue (ARR) of $2.1 billion, up 20% year over year, and remaining performance obligations of $4.1 billion, up 44%. These are measured business indicators; they do not establish the value of the second hyperscaler agreement.\n- **Management has scheduled the test:** Everpure’s September 17, 2026 announcement confirms that the September 23 analyst meeting will cover strategy, growth and the long-term financial framework. A quantified fiscal-2028 hyperscale contribution would substantiate the expansion case; its absence would leave that part of the thesis unconfirmed. [Company announcement](https://www.everpuredata.com/uk/company/newsroom/press-releases/everpure-to-host-2026-financial-analyst-meeting.html)\n\n## Bear Case\n\n- **Revenue visibility remains incomplete:** Management said on the August 26, 2026 earnings call that hyperscale revenue becomes more meaningful in fiscal 2028 and beyond, but the supplied disclosure record contains no committed volume or contract value for the second agreement. A September 23 presentation without a quantified contribution would preserve this evidence gap.\n- **Product margins constrain the story:** Second-quarter fiscal-2027 product gross margin was 66.2%, reported August 26, 2026. Management described operations near the low end of its 65%–70% product-margin range; a lower long-term margin framework on September 23 would weaken the inference that hyperscale growth improves earnings quality.\n- **Attention has outpaced price confirmation:** Benzinga’s August 27–28, 2026 ratings record listed twelve analyst actions after the earnings release. Despite that coverage, the September 18 adjusted close of $104.14 remained below the August 21 close of $108.55. The observations establish concentrated coverage and an incomplete recovery, not retail crowding or a valuation ceiling.\n\n## Setup & Price Structure\n\nThe September 18, 2026 adjusted close was $104.14, with a three-month price increase of 35.2%, RSI of 64.4 and a supplied 52-week high of $118.16. The relevant overhead reference is the August 21 close of $108.55, followed by the existing $110 weekly recovery threshold. A weekly close above $110 would confirm price recovery through that reference area; the fundamental leg still requires quantified hyperscale disclosure.\n\nThe $92 weekly threshold remains the research thesis boundary published on September 5, 2026. It is an analytical invalidation level, not a measured moving average. A weekly close below $92 would end the recovery thesis even if fiscal-2027 guidance remained unchanged.\n\nEverpure confirmed on September 8, 2026 that S&P 500 inclusion becomes effective before the September 21 open. The September 18 rebalance date identified in the previous note has passed, but no closing-auction volume or fund-flow measurements are supplied. The price rebound therefore cannot be attributed to index demand alone. [Company inclusion announcement](https://www.everpuredata.com/company/newsroom/press-releases/everpure-to-join-the-s-and-p-500.html)\n\nThe available positioning evidence is limited to clustered analyst coverage and the dated index event. The September 18 dataset contains no moving-average reading, current short-interest observation, insider-sale disclosure or issuance figure. It does not support a conclusion about who supplied the rebound.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-09-21 — S&P 500 inclusion:** Membership takes effect before the market opens, as confirmed by Everpure on September 8. This establishes the index transition date; it does not quantify incremental demand after inclusion. [Company announcement](https://www.everpuredata.com/company/newsroom/press-releases/everpure-to-join-the-s-and-p-500.html)\n- **2026-09-23 — Financial Analyst Meeting:** The event begins at 9:30 a.m. Pacific Time, according to the September 17 announcement. The research test is whether the financial framework quantifies fiscal-2028 hyperscale revenue and describes the associated product-margin economics. [Company announcement](https://www.everpuredata.com/uk/company/newsroom/press-releases/everpure-to-host-2026-financial-analyst-meeting.html)\n\nNo additional confirmed company catalyst date appears in the available evidence for the period through October 20, 2026. A date for the next earnings release is not established here.\n\n## What Would Change Our Mind\n\nLoss of the published recovery boundary would break the price thesis: a weekly close below $92 invalidates it. The September 18, 2026 close of $104.14 remains above that boundary but below the $110 confirmation threshold, leaving the recovery unresolved.\n\nThe fundamental assessment turns on the September 23 meeting. A quantified fiscal-2028 hyperscale contribution, a product-margin framework consistent with the August 26 disclosures, and a subsequent weekly close above $110 would establish the proposed recovery case. A presentation without that revenue framework would leave the catalyst case unconfirmed; a lower margin framework would weaken it.\n\nThe evidence supports a medium-conviction forecast: the August 26 revenue increase and September 18 momentum recovery support the case, while the missing contract economics and unrecovered $110 threshold limit confidence. The available observations do not establish a historical success rate for this setup.\n\n## Correlation Notes\n\nThis is a single-name setup. The supplied September 20, 2026 coverage context assigns Everpure to no active theme cluster, and the September 18 price data contain no peer-return series from which to establish correlation. Artificial-intelligence infrastructure is an economic exposure tag here, not evidence of a synchronized group move.\n\nThe August 26, 2026 management commentary connects the business to hyperscaler procurement and product mix. Those disclosures justify attention to customer spending and storage economics, but they do not establish a measured relationship with semiconductor shares or memory prices. The September 21 index inclusion is a separate market event and supplies no correlation estimate.",
  "first_seen": "2026-08-12",
  "last_analyzed": "2026-09-19T22:12:14+00:00",
  "last_synthesized": "2026-09-19",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}